(Q35699360)

English

Efficacy of infliximab in refractory Behçet's disease-associated and idiopathic posterior segment uveitis: a prospective, follow-up study of 50 patients

scientific article published on 29 December 2011

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Efficacy of infliximab in refractory Behçet's disease-associated and idiopathic posterior segment uveitis: a prospective, follow-up study of 50 patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Behçet's disease

0 references

1 reference

based on heuristic

inferred from title

author name string

Fabrizio Cantini

1

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Laura Niccoli

2

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Carlotta Nannini

3

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Olga Kaloudi

4

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Emanuele Cassarà

5

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Massimo Susini

6

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Ivo Lenzetti

7

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

29 December 2011

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Biologics: Targets and Therapy

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

5-12

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

copyright license

Creative Commons Attribution-NonCommercial 3.0 Unported

1 December 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Emerging drugs for uveitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266861

12 July 2018

Regression of optic disc neovascularization in patients with Behçet's uveoretinitis after infliximab therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266861

12 July 2018

Systematic review on the effectiveness of immunosuppressants and biological therapies in the treatment of autoimmune posterior uveitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266861

12 July 2018

Behçet's Uveitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266861

12 July 2018

The first decade of biologic TNF antagonists in clinical practice: lessons learned, unresolved issues and future directions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266861

12 July 2018

The multicenter uveitis steroid treatment trial: rationale, design, and baseline characteristics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266861

12 July 2018

Comparison of infliximab versus ciclosporin during the initial 6-month treatment period in Behçet disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266861

12 July 2018

Behçet's disease: comparing 3 decades of treatment response at the National Eye Institute

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266861

12 July 2018

Ocular inflammation in Behçet disease: incidence of ocular complications and of loss of visual acuity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266861

12 July 2018

Use of laser flare-cell photometry to quantify intraocular inflammation in patients with Behçet uveitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266861

12 July 2018

Global variation and pattern changes in epidemiology of uveitis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266861

12 July 2018

Polymorphisms of chemokine and chemokine receptor genes in idiopathic immune-mediated posterior segment uveitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266861

12 July 2018

Adalimumab for sight-threatening uveitis in Behçet's disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266861

12 July 2018

Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266861

12 July 2018

Anti-TNF-alpha therapy for sight threatening uveitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266861

12 July 2018

Infliximab in refractory uveitis due to Behçet's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266861

12 July 2018

Degree, duration, and causes of visual loss in uveitis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266861

12 July 2018

Anti-tumour necrosis factor monoclonal antibody treatment for ocular Behçet's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266861

12 July 2018

Remission of Behçet's syndrome with tumour necrosis factor alpha blocking therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266861

12 July 2018

Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266861

12 July 2018

Intraocular cytokine quantification of experimental autoimmune uveoretinitis in rats

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266861

12 July 2018

Causes and frequency of blindness in patients with intraocular inflammatory disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266861

12 July 2018

Cyclosporin in the treatment of severe chronic idiopathic uveitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266861

12 July 2018

Relationship between serum infliximab levels and acute uveitis attacks in patients with Behcet disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266861

25 September 2018

Infliximab for the treatment of refractory Adamantiades-Behçet disease with articular, intestinal, cerebral and ocular involvement

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266861

25 September 2018

Long-lasting remission of severe Behçet's disease after the end of infliximab therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266861

25 September 2018

Infliximab effects compared to conventional therapy in the management of retinal vasculitis in Behçet disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266861

25 September 2018

Interobserver agreement in grading activity and site of inflammation in eyes of patients with uveitis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266861

25 September 2018

Safety and efficacy of infliximab therapy in active behcet's uveitis: an open-label trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266861

25 September 2018

Successful treatment of severe Behçet's disease with infliximab in an Italian Olympic athlete.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266861

25 September 2018

Th1 polarization of the immune response in uveitis in Behçet's disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266861

25 September 2018

Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behçet's disease: an open-label trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266861

25 September 2018

A prospective trial of infliximab therapy for refractory uveitis: preliminary safety and efficacy outcomes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266861

25 September 2018

Infliximab for the treatment of posterior uveitis with retinal neovascularization in Behçet disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266861

25 September 2018

Long-term treatment of refractory posterior uveitis with anti-TNFalpha (infliximab).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266861

25 September 2018

Uveitis in Behçet disease: an analysis of 880 patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266861

25 September 2018

Efficacy, safety, and pharmacokinetics of multiple administration of infliximab in Behçet's disease with refractory uveoretinitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266861

25 September 2018

Infliximab for recurrent, sight-threatening ocular inflammation in Adamantiades-Behçet disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266861

25 September 2018

Infliximab in the treatment of refractory posterior uveitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266861

25 September 2018

Neutralizing tumor necrosis factor-alpha activity suppresses activation of infiltrating macrophages in experimental autoimmune uveoretinitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266861

25 September 2018

Effect of infliximab on sight-threatening panuveitis in Behçet's disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266861

25 September 2018

Referral patterns of uveitis in a tertiary eye care center.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266861

25 September 2018

Effects of infliximab in the treatment of refractory posterior uveitis of Behçet’s disease after withdrawal of infusions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266861

15 November 2018

Uveitis in London and Iowa

1 reference

https://pubmed.ncbi.nlm.nih.gov/22291462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of anti-tumour necrosis factor alpha (infliximab) on sight-threatening uveitis in a patient with Behçet's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/22291462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Infliximab in the treatment of posterior uveitis in Behçet's disease. Long term follow up in four patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/22291462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-TNF-alpha therapy in seven patients with Behcet's uveitis: advantages and controversial aspects

1 reference

https://pubmed.ncbi.nlm.nih.gov/22291462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical patterns and associated conditions in chronic uveitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22291462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/22291462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Changing patterns of uveitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22291462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased CD4+ expression and decreased IL-10 in the anterior chamber in idiopathic uveitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22291462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Aqueous Humor and Serum Tumor Necrosis Factor-α in Clinical Uveitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22291462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of infliximab on threatening panuveitis in Behçet's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/22291462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-TNFα Therapy Modulates the Phenotype of Peripheral Blood CD4+T Cells in Patients with Posterior Segment Intraocular Inflammation

1 reference

https://pubmed.ncbi.nlm.nih.gov/22291462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Infliximab for chronic cystoid macular edema associated with uveitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22291462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term safety and efficacy of infliximab therapy in refractory uveitis due to Behçet's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/22291462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term efficacy of infliximab in refractory posterior uveitis of Behcet's disease: a 24-month follow-up study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22291462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Infliximab treatment for ocular and extraocular manifestations of Behçet's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/22291462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term infliximab treatment for Behçet's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/22291462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

One year study of efficacy and safety of infliximab in the treatment of patients with ocular and neurological Behçet's disease refractory to standard immunosuppressive drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/22291462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of infliximab on the acute attack of uveitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22291462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Timing of recurrent uveitis in patients with Behcet's disease receiving infliximab treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/22291462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2147/BTT.S27343

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35699360&oldid=1868422170"